TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0241 Stock 12 Month Forecast
Average Price Target
HK$5.84
▲(9.48% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is HK$5.84 with a high forecast of HK$7.08 and a low forecast of HK$4.59. The average price target represents a 9.48% change from the last price of HK$5.33.
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$5.69
Buy
6.75%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$6.08
Buy
14.07%
Upside
Reiterated
11/30/25
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
Unknown Analyst
CICC
Not Ranked
CICC
HK$7.1
Buy
33.21%
Upside
Reiterated
11/28/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from CICC
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. MorganJPMorgan analyst Alex Yao raised the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$6.50 (from HK$5.00) while maintaining a Neutral rating.
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Alibaba Health Information Technology (Other OTC: ALBHF)
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$5.69
Buy
6.75%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$6.08
Buy
14.07%
Upside
Reiterated
11/30/25
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
Unknown Analyst
CICC
Not Ranked
CICC
HK$7.1
Buy
33.21%
Upside
Reiterated
11/28/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from CICC
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. MorganJPMorgan analyst Alex Yao raised the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$6.50 (from HK$5.00) while maintaining a Neutral rating.
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Alibaba Health Information Technology (Other OTC: ALBHF)
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$5.43
Buy
1.88%
Upside
Reiterated
05/21/25
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$7→HK$6.2
Buy
16.32%
Upside
Reiterated
05/21/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +5.90% per trade.
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -10.70% per trade.
Copying John Yung's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +26.80% per trade.
trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -22.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0241 Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
3
3
2
1
2
Buy
0
0
0
0
0
Hold
2
1
6
6
6
Sell
1
0
0
1
2
Strong Sell
0
0
0
0
0
total
6
4
8
8
10
In the current month, 0241 has received 2Buy Ratings, 6Hold Ratings, and 2Sell Ratings. 0241 average Analyst price target in the past 3 months is 5.84.
Each month's total comprises the sum of three months' worth of ratings.
0241 Financial Forecast
0241 Earnings Forecast
Next quarter’s earnings estimate for 0241 is HK$0.08 with a range of HK$0.08 to HK$0.08. The previous quarter’s EPS was HK$0.09. 0241 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0241 is HK$0.08 with a range of HK$0.08 to HK$0.08. The previous quarter’s EPS was HK$0.09. 0241 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.
0241 Sales Forecast
Next quarter’s sales forecast for 0241 is HK$20.50B with a range of HK$20.29B to HK$20.70B. The previous quarter’s sales results were HK$18.13B. 0241 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0241 is HK$20.50B with a range of HK$20.29B to HK$20.70B. The previous quarter’s sales results were HK$18.13B. 0241 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.
0241 Stock Forecast FAQ
What is HK:0241’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology’s 12-month average price target is 5.84.
What is HK:0241’s upside potential, based on the analysts’ average price target?
Alibaba Health Information Technology has 9.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Alibaba Health Information Technology a Buy, Sell or Hold?
Alibaba Health Information Technology has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 2 hold ratings and 1 sell ratings.
What is Alibaba Health Information Technology’s share price target?
The average share price target for Alibaba Health Information Technology is 5.84. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$7.08 ,and the lowest forecast is HK$4.59. The average share price target represents 9.48% Increase from the current price of HK$5.33.
What do analysts say about Alibaba Health Information Technology?
Alibaba Health Information Technology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of Alibaba Health Information Technology?
To buy shares of HK:0241, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.